ENDRA Life Sciences Net Income

The latest net income for NDRA is $-7.3M as of March 2026. That compares with $-9.9M in the prior-year period — up 26.1% year over year. That is below the Technology sector average of $6.3T. Investors often review this figure alongside ENDRA Life Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, NDRA's net income moved from $-9.9M to $-7.3M — a 26.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ENDRA Life Sciences's operating scale or balance-sheet position.

Against Technology companies, NDRA currently prints $-7.3M for net income, while the sector average sits near $6.3T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at ENDRA Life Sciences's growth, margins, and balance sheet.

A net income figure of $-7.3M for NDRA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Technology average is about $6.3T. Explore the charts below for those layers of context.

After noting NDRA's net income ($-7.3M), review year-over-year change from $-9.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.